The fatty acid synthase (FAS) from Brevibacterium ammoniagenes is a homohexameric multienzyme complex that catalyzes the synthesis of both saturated and unsaturated fatty acids. By immunological screening of a B. ammoniagenes expression library, an fas DNA fragment was isolated and subsequently used to clone the entire gene together with its flanking sequences. Within 10,525 bp of sequenced DNA, the 9,189-bp FAS coding region was identified, corresponding to a protein of 3,063 amino acids with a molecular mass of 324,910 Da. This gene (fasA) encodes, at its 5 end, the same amino acid sequence as is observed with purified B. ammoniagenes FAS. A second reading frame encoding another B. ammoniagenes FAS variant (FasB) had been identified previously. Both sequences are colinear and exhibit 61 and 47% identity at the DNA and protein levels, respectively. By using specific antibodies raised against a unique peptide sequence of FasB, this enzyme was shown to represent only 5 to 10% of the cellular FAS protein. Unlike the majority of procaryotes, the coryneform bacterium Brevibacterium ammoniagenes contains an aggregated type I fatty acid synthase (FAS) multienzyme complex (5, 6). Apart from B. ammoniagenes, FAS proteins with this structural organization have also been found within the genera Mycobacterium (7, 26) and Corynebacterium (1). The taxonomic relatedness of B. ammoniagenes to corynebacteria in particular had already been proposed earlier, mainly on the basis of the occurrence of mycolic acid as a common constituent of their cell walls (24). In type I FASs, at least eight functionally different catalytic domains are integrated into either a single (bacteria, animals) or two different (fungi) multifunctional proteins (13). According to the pioneering work of Kawaguchi and coworkers (17), the B. ammoniagenes FAS complex is an ␣ 6 homomultimer with a molecular mass of about 2.0 MDa. In contrast to the eucaryotic FAS enzymes, but like the dissociated type II bacterial FAS systems (3, 14), the B. ammoniagenes type I FAS contains a 3-hydroxydecanoyl-␤,␥-dehydratase as an additional component; thus, both saturated and unsaturated fatty acids are synthesized by this enzyme (5). In a first attempt to investigate the molecular structure of this exceptional multifunctional FAS protein in more detail, we recently isolated and sequenced a 9,312-bp fas-like reading frame from B. ammoniagenes (16). The gene product encoded by this DNA exhibited 46% sequence similarity to yeast FAS, and its order of catalytic domains was colinear to a hypothetical head-to-tail fusion of the two yeast FAS subunits (16). However, disruption of this fas-like reading frame produced no FAS-defective B. ammoniagenes mutants, indicating that either it is not an FAS coding gene of B. ammoniagenes at all or it is not the only one. As will be reported in this paper, a continued immunological search indeed resulted in the isolation of a second B. ammoniagenes fas gene. Unlike the previously isolated fas-like DNA, the coding region for the N-terminal amino acid sequence of purified B. ammoniagenes FAS corresponded to this newly isolated coding sequence. On the basis of the observation that, in vivo, both B. ammoniagenes fas genes are expressed but that disruption of only one of them produces a fatty acid-requiring phenotype, the differential functions of the two genes are discussed.
Unlike the majority of procaryotes, the coryneform bacterium Brevibacterium ammoniagenes contains an aggregated type I fatty acid synthase (FAS) multienzyme complex (5, 6) . Apart from B. ammoniagenes, FAS proteins with this structural organization have also been found within the genera Mycobacterium (7, 26) and Corynebacterium (1) . The taxonomic relatedness of B. ammoniagenes to corynebacteria in particular had already been proposed earlier, mainly on the basis of the occurrence of mycolic acid as a common constituent of their cell walls (24) . In type I FASs, at least eight functionally different catalytic domains are integrated into either a single (bacteria, animals) or two different (fungi) multifunctional proteins (13) . According to the pioneering work of Kawaguchi and coworkers (17) , the B. ammoniagenes FAS complex is an ␣ 6 homomultimer with a molecular mass of about 2.0 MDa. In contrast to the eucaryotic FAS enzymes, but like the dissociated type II bacterial FAS systems (3, 14) , the B. ammoniagenes type I FAS contains a 3-hydroxydecanoyl-␤,␥-dehydratase as an additional component; thus, both saturated and unsaturated fatty acids are synthesized by this enzyme (5) . In a first attempt to investigate the molecular structure of this exceptional multifunctional FAS protein in more detail, we recently isolated and sequenced a 9,312-bp fas-like reading frame from B. ammoniagenes (16) . The gene product encoded by this DNA exhibited 46% sequence similarity to yeast FAS, and its order of catalytic domains was colinear to a hypothetical head-to-tail fusion of the two yeast FAS subunits (16) . However, disruption of this fas-like reading frame produced no FAS-defective B. ammoniagenes mutants, indicating that either it is not an FAS coding gene of B. ammoniagenes at all or it is not the only one. As will be reported in this paper, a continued immunological search indeed resulted in the isolation of a second B. ammoniagenes fas gene. Unlike the previously isolated fas-like DNA, the coding region for the N-terminal amino acid sequence of purified B. ammoniagenes FAS corresponded to this newly isolated coding sequence. On the basis of the observation that, in vivo, both B. ammoniagenes fas genes are expressed but that disruption of only one of them produces a fatty acid-requiring phenotype, the differential functions of the two genes are discussed.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and DNA isolation. Escherichia coli DH5␣, Y1090r, and XL1 Blue MRA(P2), used for screening and amplification of recombinant phage and plasmid vectors, were purchased from Gibco/BRL (DH5␣) and Stratagene, respectively. Other bacterial strains and the plasmids used for B. ammoniagenes transformation are listed in Table 1 . B. ammoniagenes cells were grown at 30ЊC either in Luria broth (18) or in GCY medium (containing [per liter] 10 g of glucose, 10 g of Casamino Acids, 10 g of yeast extract [Gibco] , and 3 g of NaCl), pH 7.3. Whenever indicated, media contained, in addition, kanamycin (50 or 20 mg/l). The lower antibiotic concentration was used when selecting for B. ammoniagenes conjugants, while the higher one served to ensure the stable propagation of transformants. Fatty acid-requiring mutants were supplemented with 0.03% oleic acid in the presence of 1% Tween 40. Alternatively, Brij 58 may have been used as a detergent.
Chromosomal DNA was isolated from wild-type and mutant B. ammoniagenes cells essentially as described by Meurer et al. (16) except that there was an additional incubation with RNase A (50 g/ml) during cell lysis followed by an intensified proteinase K treatment (300 instead of 50 g/ml). For plasmid isolation, B. ammoniagenes cells were suspended in TE buffer (50 mM Tris-HCl-10 mM EDTA, pH 8.0) and incubated with lysozyme (5 mg/ml) for 1 h at 37ЊC. Otherwise, the method of Birnboim and Doly (2) was followed. If necessary, plasmids were further purified on Quiagen ion-exchange columns (Diagen) according to the recommendations of the manufacturer.
DNA manipulation and computational techniques. Standard molecular biological techniques, such as PCR and Southern hybridization experiments, immunological screening for recombinants, and plasmid manipulations, were performed as described elsewhere (18) . For DNA sequencing by the dideoxy chain termination method of Sanger et al. (19) , [␣- 35 S]-dATP was used along with the T7 Sequencing Kit from Pharmacia. Derivatives of plasmids pUC18 and pUC19 were used as sequencing templates throughout this work (18) . Long-distance sequencing was performed by primer walking. Whenever necessary, sequence anomalies were resolved using 7-deaza-dGTP/dATP (Pharmacia) instead of dGTP/dATP. Sequencing primers were purchased from MWG Biotech (Ebersberg, Germany). The B. ammoniagenes lambda gt11 expression library and an EMBL3 library were constructed as described by Meurer et al. (16) . Analysis of DNA and protein sequence data was done using the University of Wisconsin Genetics Computer Group sequence analysis software package, version 7.1. Sequence alignments were performed with the BestFit or PileUp programs using standard parameters.
Transformation of B. ammoniagenes cells. Conjugational plasmid transfer from E. coli S 17-1 (25) to B. ammoniagenes wild-type and mutant cells was performed according to the method of Schäfer et al. (20) . All plasmids used for B. ammoniagenes transformation were derivatives of the vector pECM1 (20) . For electroporation, cells were grown to mid-log phase and washed five times with cold 10% glycerol. At this stage, cells could be stored at Ϫ70ЊC. To obtain good yields of transformants, it was necessary to amplify the plasmid DNA in B. ammoniagenes rather than in E. coli cells. Approximately 0.5 g of plasmid DNA was used for electroporation in a Bio-Rad Gene Pulser at 200 ⍀, 25 F, and 1.6 kV using an electroporation cuvette with a light path of 0.1 cm. The time constants thereby obtained were between 2.5 and 3.2 ms. After electroporation, cells were immediately incubated with ice-cold GCY medium containing 50 mM CaCl 2 and 50 mM MgSO 4 and placed on ice for 15 min. For cell regeneration, the suspension was diluted with standard GCY medium and incubated for 6 h at 30ЊC before being plated on kanamycin-containing selective media.
FAS purification and assays. The FAS purification procedure used for these studies was that originally described by Lynen (12) for the yeast FAS complex, with the following modifications. Frozen B. ammoniagenes cells (100 g) were suspended in 200 ml of 0.4 M potassium phosphate buffer, pH 7.5, containing 2 mM dithiothreitol. For inhibition of proteases, 100 mg of phenylmethanesulfonate (dissolved in 1 ml of acetone) was added. Cells were disrupted with glass beads at 4ЊC. The homogenate was fractionated by addition of ammonium sulfate, first to 30% and subsequently to 65% saturation. The 65% precipitate was dissolved in 0.1 M potassium phosphate, pH 7.5, and the FAS complex was sedimented by ultracentrifugation (100,000 ϫ g for 10 h). The precipitate was dissolved in about 12 ml of 0.4 M potassium phosphate, pH 7.3, containing 2 mM dithiothreitol, and the resulting solution was then subjected to a 3-h centrifugation in a linear 5 to 25% sucrose density gradient at 185,000 ϫ g in a Sorvall TV850 rotor. The FAS-containing fractions were collected, and the FAS complex was precipitated by addition of ammonium sulfate to 70% saturation. The precipitate was dialysed against 0.1 M potassium phosphate, pH 7.3, for 3 h. Subsequently, a second 5 to 25% sucrose density gradient centrifugation was performed for 20 h at 85,000 ϫ g in a Beckman SW28 rotor. From the FAScontaining fractions, the complex was again sedimented by a 10-h centrifugation at 100,000 ϫ g. Finally, the enzyme was dissolved in 0.1 M potassium phosphate buffer, pH 7.3, and subjected to fast protein liquid chromatography on a Superose 6 HR 10/30 gel filtration column (Pharmacia). The purity of the resulting FAS preparation was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (9) . The acrylamide concentration was 3% for the stacking gel and 5% for the running gel. FAS activity was assayed according to the method of Lynen (12) .
Immunological techniques. The production of a polyclonal antiserum against the purified B. ammoniagenes FAS was described previously (16) . Domainspecific antisera against synthetic B. ammoniagenes FAS peptides were prepared by coupling them to keyhole limpet hemocyanin essentially as described by Liu et al. (11) . FAS-specific peptides were synthesized by D. Palm (University of Würzburg, Würzburg, Germany). The keyhole limpet hemocyanin protein and the coupling reagent, 3-maleimidobenzoyl-N-hydroxysuccinimide ester, were purchased from Boehringer GmbH (Mannheim, Germany).
Western blotting (immunoblotting) was performed as described previously (21) .
Nucleotide sequence accession numbers. The B. ammoniagenes fasA sequence reported in this paper has been submitted to the EMBL data bank and was assigned the accession number X 87822. The previously sequenced fasB gene has the accession number X 64795.
RESULTS

Purification of B. ammoniagenes FAS. The B. ammoniagenes
FAS was isolated by a refined purification protocol relying mostly on separation methods based on the extraordinarily large molecular mass of this enzyme. The purified FAS protein thereby obtained proved to be homogeneous upon SDS-PAGE. By N-terminal sequencing, the 21-amino-acid sequence SLTPLHTLSNDSTAPAVLFAG was clearly established. This sequence was obviously different from the N-terminus sequence deduced from the previously isolated B. ammoniagenes fas gene. Therefore, the product of the gene (Fig. 1) , was sequenced and proved to be free of stop codons in one of its reading frames. The deduced amino acid sequence exhibited significant similarity to the malonyl-palmitoyl transferase domain of the Saccharomyces cerevisiae FAS. As is evident from Fig. 2 , this newly isolated FAS sequence (positions 1473 to 2078) was not identical to the corresponding region of the previously isolated B. ammoniagenes fas gene, although there were distinctive similarities. Thus, the BF1 DNA fragment was considered to be part of the second B. ammoniagenes fas gene that had been sought.
In order to isolate the N-and C-terminal flanking regions of BF1, an EMBL3 library containing B. ammoniagenes DNA partially digested with Sau3A was screened by plaque hybridization with BF1. Three phage clones were thereby isolated, with overlapping inserts of 14.2, 17, and 16.2 kb (data not shown). From these three clones, the plasmid subclones pBF13, pCT, and pCT102 were derived, covering about 16 kb of contiguous DNA on the B. ammoniagenes genome (Fig. 1) . Within this DNA, a segment 10,525 bp in length was sequenced in both directions (Fig. 1) . The sequenced DNA contains a 9,189-bp open reading frame with coding capacity for a protein of 3,063 amino acids with a molecular mass of 324,910-Da. The encoded protein exhibits significant sequence similarity (47% identical residues and 65% conserved positions) to the previously characterized fas-like gene (16) of B. ammoniagenes (Fig. 2) . In order to exclude strain-specific variations between the fas DNA analyzed in this work and that formerly studied by Meurer and coworkers (16), we reisolated distinct segments of both genes from a single B. ammoniagenes colony by PCR cloning. Sequencing of the isolated PCR fragments confirmed that both fas genes were indeed present in the same cell (data not shown). We therefore named the two genes fasA and fasB.
At the DNA level, fasA and fasB exhibit 61% overall sequence similarity. The similarity extends over the entire lengths of the genes, although to a variable extent. This colinearity suggests that the order of the catalytical FAS domains along the two multifunctional protein chains is identical (Fig.  2) . Similarly, both FAS proteins correspond formally to a headto-tail fusion of the yeast FAS subunits ␤ and ␣, as was pointed out earlier for the fasB sequence (16) . Unlike that of FasB, the amino acid sequence deduced for FasA was consistent with the experimentally determined N-terminal sequence of the purified B. ammoniagenes FAS (Fig. 2) . From this it can be concluded that the fasA gene isolated in this study actually encodes the FAS predominantly produced in B. ammoniagenes cells. Since fasA and fasB are expected to encode proteins of very similar size, they ought to be copurified by the isolation procedure used. The predominance of FasA within the purified FAS preparation, as evidenced by N-terminal sequencing data, suggests that FasB is synthesized either at a very low level or only under specific conditions. Differential expression rates of the two B. ammoniagenes fas genes. In order to assay the differential expression rates of fasA and fasB, specific antibodies were prepared against an internal 19-amino-acid peptide of FasB. This peptide, QVVSTDE GQAALFDVGQAP, corresponding to positions 336 to 355 in Fig. 2 , exhibits very low sequence similarity to FasA. In contrast, the polyclonal antiserum prepared against purified B. ammoniagenes FasA presumably reacts with both FasA and FasB. Crude cell extracts of B. ammoniagenes wild-type and fasB-disrupted cells (see below) were subjected to Western blot analysis with the two FAS antisera mentioned. As demonstrated in Fig. 3 , the antibodies against purified B. ammoniagenes FAS produced a strong immunopositive signal with both wild-type and fasB-disrupted cell extracts (Fig. 3A, lanes  1 and 2) . On the other hand, the antibodies directed against the FasB peptide elicited only a faint, though distinct, immunopositive reaction with the wild-type extract (Fig. 3B, lane 2) . As expected, this band was absent in fasB-disrupted cells (Fig.  3B, lane 1) . These findings confirm that the FasB antiserum is indeed specific for this FAS variant. In addition, they demonstrate that fasB is not a silent gene but is expressed, under the conditions applied here, at a definite (though considerably lower) rate than fasA. Expression of both FAS variants is drastically increased in B. ammoniagenes transformants containing multiple copies of the respective fasB and fasA genes. The corresponding Western blot and SDS-PAGE patterns are shown in Fig. 3B and C, respectively. Essentially the same results were obtained with Northern (RNA) blot analyses with specific fasA and fasB hybridization probes. In these experiments, on the background of a considerable smear of degradation products, the fasA probe gave a strong signal while the fasB signal was not above background (data not shown). This suggests that the differential expression of the fasA and fasB genes may occur at the transcriptional level.
Disruption of fasA and fasB reading frames by insertional mutagenesis. In separate experiments, each of the two B. ammoniagenes fas genes was disrupted, at the chromosomal level, by targeted integration of either one of the suicide plasmids pDV2 and pECM⌬SHM. These plasmids contained, respectively, the central 1.8-kb EcoRI fragment (BF1) of the fasA gene and a homologous 1.5-kb SphI-HindIII fragment derived from the fasB gene. The suicide vector pECM⌬, which was used to construct both insertion plasmids, was derived from the E. coli-B. ammoniagenes shuttle vector pECM1 by elimination of the 2.4-kb SphI fragment containing the DNA element responsible for autonomous replication in B. ammoniagenes. Transformants which had stably integrated the above-mentioned constructs were selected on fatty acid-containing media according to their acquired kanamycin resistance. The plasmid insertion was expected to destroy the fas reading frames by disrupting them into two halves (Fig. 4B) . The proximal ends of both halves contain a duplicated fas sequence resulting from the recombinational event. By the same mechanism, the integrated DNA may be eliminated again, thereby restoring the original, functionally intact fas DNA. This occurs readily if the selective agent, kanamycin, is omitted from the growth media. For both the fasA and fasB genes, successful disruption was confirmed by Southern hybridization (Fig. 4A) . In each case, the respective fas restriction fragments were shifted to the expected higher-molecular-mass positions in the gel.
The capacities of fas-inactivated B. ammoniagenes cells for saturated and unsaturated fatty acid biosynthesis were examined by replica plating onto fatty acid-free selective media and onto media supplemented with palmitic and oleic acid, respectively. It turned out that fasB disruptants exhibited no fatty acid requirement whatsoever. In contrast, fasA disruptants required oleic acid for growth and failed to grow on kanamycin-containing, fatty acid-free media. Palmitic or stearic acid supplementation did not allow growth under these conditions. These Complementation of oleic acid-requiring B. ammoniagenes mutants by fasA DNA. Previous attempts in our laboratory to obtain, by ethyl methanesulfonate (EMS) mutagenesis, fatty acid-requiring B. ammoniagenes mutants resulted exclusively in the isolation of oleic acid-dependent strains (15) . These results are consistent with the characteristics of the previously described fasA insertional mutants and confirm the idea that there exists only one oleic acid-synthesizing FAS system in B. ammoniagenes while the capacity to synthesize saturated fatty acids must be redundant. The differential biosynthetic characteristics of fasA and fasB were again demonstrated by transforming the EMS-induced oleic acid-requiring mutants alternatively with either one of the fasA or fasB DNA-containing plasmids. As is evident from Fig. 5 , the wild-type phenotype was restored in fasA-transformed cells but not in fasB-transformed cells. These complementation data are consistent with the aforementioned fas inactivation results, confirming that fasA has the capacity to catalyze the synthesis of oleic acid but fasB does not.
The B. ammoniagenes transformations described in this work were performed by both conjugational plasmid transfer and electroporation. The efficiency of conjugational plasmid transfer to the B. ammoniagenes ATCC 6871 wild-type cells was in accordance with data described for the related strain B. ammoniagenes ATCC 6872 (20) . In contrast, plasmid transfer to the oleic-acid-requiring mutants isolated in this work was significantly less efficient (Ͻ10% of that of the wild type). On the other hand, reproducibly high transformation rates for both wild-type and mutant cells were obtained by electroporation. However, with this technique, high transformation rates were observed only when plasmid amplification prior to transformation was carried out in B. ammoniagenes rather than in E. coli DH5␣. Under optimal conditions, up to 10 5 transformants per g of DNA could thus be obtained. The transformational inefficiency of the E. coli-derived plasmid DNA suggests the existence of a stringent restriction-modification system in B. ammoniagenes ATCC 6871. In this respect, B. ammoniagenes conforms to the characteristics of Corynebacterium glutamicum reported by Liebl et al. (10) .
DISCUSSION
The isolation of fasA-and fasB-defective B. ammoniagenes mutants, as described in this study, provides the first insight into the differential functions of these two bacterial FAS complexes. If both enzymes were functionally identical, no phenotypically defective fas mutants should be observed. Indeed, insertional inactivation of fasB did not have any phenotypic (15) . Obviously, the origin of saturated fatty acids in fasA-defective mutants lacking the predominant cellular FAS complex remains to be elucidated.
As an alternative to the unaffected FasB enzyme, they could also originate from a third, as yet unidentified, possibly nonaggregated B. ammoniagenes FAS. Compared with these alternatives, it appears rather unlikely that any palmitate-synthesizing activity has remained with the two gene fragments produced by the fasA disruption process. The availability of the specifically fasA-or fasB-defective B. ammoniagenes mutants described in this study provides the opportunity to perform detailed in vitro biochemical studies on the biosynthetic capacities of both enzymes. From these mutants, homogeneous preparations of each Fas enzyme may now be isolated. In principle, only a mixture of both enzymes should be obtained from B. ammoniagenes wild-type cells. At least the minor variant, FasB, was thereby not accessible for biochemical characterization. The three transacylase active sites as well as the reactive cysteinyl residue of the ␤-ketoacyl synthase have been assigned to distinct locations within FasA and FasB according to their sequence similarities to the corresponding sites within yeast FAS (Fig. 2 ). These yeast sites had originally been identified by substrate binding studies and by peptide sequencing of appropriate acyl enzyme intermediates (4, 8, 22) . Similarly, the pantetheine-binding serine residue in yeast FAS was identified by sequencing of radioactively labelled holoenzyme fragments (22) . So far, this analysis has not been performed with the two B. ammoniagenes type I FAS enzymes. Hence, the assignment of pantetheine binding sites in FasA and FasB indicated in Fig.  2 remains tentative and is based on their overall sequence similarities to the corresponding yeast FAS regions (16) . In contrast to the aforementioned catalytic sites, the ketoreductase, enoyl reductase, and dehydratase domains cannot be labelled by substrate binding. Instead, they have been localized by deletion mapping of appropriate yeast FAS mutations (23) . Because of the colinearity of their overall sequences, the respective domains in the B. ammoniagenes fasA and fasB genes have been attributed to positions corresponding to those of the yeast enzyme. In contrast to the activities involved in saturated fatty acid synthesis, nothing is known about the location of the components required for oleic acid production, i.e., the putative 3-hydroxydodecanoyl-FAS dehydratase and dodecenoylCoA catalyzes this reaction but FasB does not, the two FAS enzymes should characteristically differ, at least within restricted parts of their structures. A scrutinous comparison of FasA and FasB was performed to determine if this is the case. It revealed that apart from the colinearity and sequence similarity of FasA and FasB, in general there is specifically one region of about 200 amino acids in length where this similarity is rather low if significant at all (positions 860 to 1070 in Fig. 2) . Therefore, future studies aimed at the characterization of enzymatic functions specifically involved in oleic acid biosynthesis may have to concentrate on this part of FasA.
